Dr Roberta Di Blasi (Hospital Saint-Louis, France) studied infection complications of chimeric antigen receptors T cells (CAR-T) treatment in diffuse large B cell lymphoma (DLBCL) patients . She concluded that febrile neutropenia is a frequent complication and that it can be difficult to distinguish infections from beginning cytokine release syndrome (CRS). Bacterial and viral infection have low incidence and fungal infections did not occur in this cohort at all. Infectious complications appear mild and not fatal. Longer follow-up for immune recovery/infectious complications is needed, as well as broader studies to better define infectious risk in this subset of patients.
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Early trial data shows positive results for treating anaemia in patients with end-stage renal failure Next Article
Haematopoietic stem cells can sense tissue damage in the gut »
Table of Contents: EHA 2019
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.